» Articles » PMID: 28617331

Hormesis and Defense of Infectious Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Jun 16
PMID 28617331
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Infectious diseases are a global health burden and remain associated with high social and economic impact. Treatment of affected patients largely relies on antimicrobial agents that act by directly targeting microbial replication. Despite the utility of host specific therapies having been assessed in previous clinical trials, such as targeting the immune response via modulating the cytokine release in sepsis, results have largely been frustrating and did not lead to the introduction of new therapeutic tools. In this article, we will discuss current evidence arguing that, by applying the concept of hormesis, already approved pharmacological agents could be used therapeutically to increase survival of patients with infectious disease via improving disease tolerance, a defense mechanism that decreases the extent of infection-associated tissue damage without directly targeting pathogenic microorganisms.

Citing Articles

Study on health education methods based on rural residents' infectious disease-specific health literacy in Shandong, China.

Chen S, Wang B, Wang X, Shi K, Cui W, Liu Y Medicine (Baltimore). 2024; 103(32):e39292.

PMID: 39121244 PMC: 11315526. DOI: 10.1097/MD.0000000000039292.


A comprehensive review for machine learning based human papillomavirus detection in forensic identification with multiple medical samples.

Yao H, Zhang X Front Microbiol. 2023; 14:1232295.

PMID: 37529327 PMC: 10387549. DOI: 10.3389/fmicb.2023.1232295.


Cooperation between physiological defenses and immune resistance produces asymptomatic carriage of a lethal bacterial pathogen.

Chen G, Thorup N, Miller A, Li Y, Ayres J Sci Adv. 2023; 9(25):eadg8719.

PMID: 37352357 PMC: 10289649. DOI: 10.1126/sciadv.adg8719.


Cooperation between physiological defenses and immune resistance produces asymptomatic carriage of a lethal bacterial pathogen.

Chen G, Thorup N, Miller A, Li Y, Ayres J bioRxiv. 2023; .

PMID: 36711884 PMC: 9882269. DOI: 10.1101/2023.01.22.525099.


Interactions of Microbiota and Mucosal Immunity in the Ceca of Broiler Chickens Infected with .

Choi J, Kim W Vaccines (Basel). 2022; 10(11).

PMID: 36423036 PMC: 9693493. DOI: 10.3390/vaccines10111941.


References
1.
Wan S, Shi B, Lou X, Liu J, Ma G, Liang D . Ghrelin protects small intestinal epithelium against sepsis-induced injury by enhancing the autophagy of intestinal epithelial cells. Biomed Pharmacother. 2016; 83:1315-1320. DOI: 10.1016/j.biopha.2016.08.048. View

2.
Yang Q, Ghose P, Ismail N . Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock. Infect Immun. 2013; 81(5):1751-63. PMC: 3647993. DOI: 10.1128/IAI.01409-12. View

3.
Rodrigue-Gervais I, Labbe K, Dagenais M, Dupaul-Chicoine J, Champagne C, Morizot A . Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe. 2014; 15(1):23-35. DOI: 10.1016/j.chom.2013.12.003. View

4.
. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 385(9963):117-71. PMC: 4340604. DOI: 10.1016/S0140-6736(14)61682-2. View

5.
Raberg L, Sim D, Read A . Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science. 2007; 318(5851):812-4. DOI: 10.1126/science.1148526. View